Background and Aims: To examine characteristics of first-time methadone and buprenorphine clients and factors associated with risk of leaving first treatment in New South Wales (NSW), Australia. Design: Retrospective linkage study of opioid substitution therapy (OST) treatment, court, custody and mortality data. Setting: NSW, Australia. Participants: First-time OST entrants (August 2001–December 2010). Measurements: Characteristics of clients were examined. Time-dependent Cox models examined factors associated with the risk of leaving first treatment, with demographic, criminographic and treatment variables jointly considered. Interactions between medication and other variables upon risk of leaving treatment were examined.Findings: There we...
This prospective patient-preference study examined the effectiveness in practice of methadone versus...
Background: Opioid dependence is associated with substantial health and social burdens, and opioid a...
BACKGROUND: Guidelines recommend long-term treatment for opioid use disorder including the use of bu...
Background and Aims: To examine characteristics of first-time methadone and buprenorphine clients an...
BACKGROUND AND AIMS: To examine characteristics of first-time methadone and buprenorphine clients an...
First published: 12 May 2021Background and Aims: There is limited evidence on the relationship betwe...
The aims of this study were to: examine the number and characteristics of patients entering and re-e...
The purpose of this study is to compare retention in treatment and mortality among people entering m...
AbstractBackground and Aims: There is limited evidence on the relationship between retention in opio...
AimsTo examine patient and medication characteristics associated with retention and continued illici...
AIMS: To characterize comparative risks and benefits of methadone versus buprenorphine/naloxone in a...
Retention in treatment is a key indicator of methadone treatment success. The study aims to identify...
Background: Opioid substitution therapy (OST) with buprenorphine has been widely available in India ...
Background: Heroin dependence is associated with high mortality. Opioid agonist treatment (OAT) with...
The definitive version is available at www.blackwell-synergy.comAIMS: To assess the efficacy of bupr...
This prospective patient-preference study examined the effectiveness in practice of methadone versus...
Background: Opioid dependence is associated with substantial health and social burdens, and opioid a...
BACKGROUND: Guidelines recommend long-term treatment for opioid use disorder including the use of bu...
Background and Aims: To examine characteristics of first-time methadone and buprenorphine clients an...
BACKGROUND AND AIMS: To examine characteristics of first-time methadone and buprenorphine clients an...
First published: 12 May 2021Background and Aims: There is limited evidence on the relationship betwe...
The aims of this study were to: examine the number and characteristics of patients entering and re-e...
The purpose of this study is to compare retention in treatment and mortality among people entering m...
AbstractBackground and Aims: There is limited evidence on the relationship between retention in opio...
AimsTo examine patient and medication characteristics associated with retention and continued illici...
AIMS: To characterize comparative risks and benefits of methadone versus buprenorphine/naloxone in a...
Retention in treatment is a key indicator of methadone treatment success. The study aims to identify...
Background: Opioid substitution therapy (OST) with buprenorphine has been widely available in India ...
Background: Heroin dependence is associated with high mortality. Opioid agonist treatment (OAT) with...
The definitive version is available at www.blackwell-synergy.comAIMS: To assess the efficacy of bupr...
This prospective patient-preference study examined the effectiveness in practice of methadone versus...
Background: Opioid dependence is associated with substantial health and social burdens, and opioid a...
BACKGROUND: Guidelines recommend long-term treatment for opioid use disorder including the use of bu...